go 6976 has been researched along with sb 216763 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alessi, DR; Arthur, JS; Bain, J; Cohen, P; Elliott, M; Hastie, CJ; Klevernic, I; McLauchlan, H; Plater, L; Shpiro, N | 1 |
Brunner-Weinzierl, MC; Hollenbach, E; Kandolf, R; Kavuri, S; Klar, S; Klingel, K; Leverkus, M; Neumann, M; Wilisch-Neumann, A | 1 |
2 other study(ies) available for go 6976 and sb 216763
Article | Year |
---|---|
The selectivity of protein kinase inhibitors: a further update.
Topics: Amino Acid Sequence; Animals; Cell Line; Drug Design; Enzyme Activation; Humans; Mitogen-Activated Protein Kinases; Phosphorylation; Protein Kinase Inhibitors; Recombinant Proteins; Spodoptera | 2007 |
Glycogen synthase kinase-3β is a crucial mediator of signal-induced RelB degradation.
Topics: Carbazoles; Enzyme Inhibitors; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Immunoblotting; Immunoprecipitation; Indoles; Jurkat Cells; Maleimides; Mutation; Phosphorylation; Protein Binding; Protein Kinase C; Pyrroles; RNA Interference; Signal Transduction; Substrate Specificity; Transcription Factor RelB | 2011 |